How to Export FDA-Regulated Products to the US from China

What Are the FDA Requirements for Chinese Exporters?

Chinese companies exporting to the US face the same foundational FDA requirements as other foreign manufacturers, but with heightened enforcement attention. The core requirements are:

• FDA Facility Registration: All manufacturing, processing, and packaging facilities must be registered with FDA. This applies to food, drug, device, and cosmetics facilities.
• US Agent Designation: A US-based representative must be designated to receive FDA communications.
• Product Listing: Drugs, devices, and cosmetics must be individually listed. Food products require Prior Notice filings.
• Current Good Manufacturing Practices (cGMP): Drug and device facilities must demonstrate compliance with cGMP regulations. FDA conducts inspections of Chinese facilities.
• Labeling: All products must carry English-language labels that comply with FDA formatting and content requirements.

Do Chinese Companies Need a US Agent?

Yes. Every Chinese facility registered with FDA must designate a US Agent located in the United States. Given the volume of FDA communications directed at Chinese facilities, including import alerts, warning letters, and inspection notices, having a responsive and knowledgeable US Agent is especially important.

A professional US Agent service provides several advantages for Chinese exporters: prompt forwarding of FDA correspondence in Mandarin or English, expertise in navigating import alerts, and 24/7 availability during US business hours. The 12–13 hour time difference between China and the US East Coast makes a US-based agent essential for timely FDA responses.

Import Alerts Affecting Chinese Products

Import alerts allow FDA to detain products without physical examination based on a history of violations. China has more active import alerts than any other exporting country. Key import alerts affecting Chinese products include:

Chinese exporters can petition FDA to be removed from an import alert by demonstrating corrective actions and submitting evidence of compliance. This process typically takes 3–6 months and requires documentation of root cause analysis, corrective actions, and independent laboratory testing.

Food Safety and FSMA Compliance

The Food Safety Modernization Act (FSMA) significantly increased FDA's oversight of imported food. Chinese food exporters must address these FSMA requirements:

Preventive Controls

Chinese food facilities must have a written food safety plan with hazard analysis, preventive controls, monitoring procedures, and corrective actions. While FDA does not directly enforce preventive controls at foreign facilities, the US importer's FSVP program will verify that your facility meets these standards.

Foreign Supplier Verification Program (FSVP)

US importers of Chinese food products must conduct supplier verification activities. Chinese exporters should expect requests for hazard analysis documentation, third-party audit reports, and testing certificates. Maintaining these records proactively strengthens your position with US importers.

Prior Notice

Every food shipment from China requires a Prior Notice filing with FDA before arrival at a US port. Missing or inaccurate Prior Notice filings result in automatic refusal.

Medical Device Exports from China

China is a major manufacturer of medical devices, from PPE and diagnostic equipment to surgical instruments and implants. Chinese device manufacturers must comply with:

• FDA Establishment Registration: Annual registration with the registration fee (over $8,000 for FY2026).
• Device Listing: Each device must be listed with its product code and FDA classification.
• Premarket Clearance: Most Class II devices require 510(k) clearance. Class III devices require PMA approval. Only certain Class I devices are exempt.
• Quality System Regulation (QSR): Compliance with 21 CFR 820 is mandatory. FDA inspects Chinese device facilities, and inspection findings (Form 483 observations) can lead to warning letters and import alerts.
• MDR Reporting: Mandatory reporting of device malfunctions, serious injuries, and deaths related to the device.

Drug and API Exports

China is a major supplier of active pharmaceutical ingredients (APIs) and finished dosage forms to the US pharmaceutical supply chain. Regulatory requirements include:

• Drug Establishment Registration: Annual registration with the annual establishment fee (over $7,600 for FY2026).
• Drug Listing: Each drug product must be listed with its NDC number.
• cGMP Compliance: Drug facilities must comply with 21 CFR Parts 210 and 211. FDA has significantly increased the frequency of inspections at Chinese drug facilities.
• Drug Master Files (DMF): API manufacturers typically file a DMF with FDA to support their customers' drug applications.
• Data Integrity: FDA has issued multiple warning letters to Chinese drug facilities for data integrity violations. Maintaining robust electronic records and audit trails is essential.

Common Compliance Failures for Chinese Exporters

Based on FDA enforcement data, these are the most frequent compliance failures for Chinese companies:

How Much Does FDA Registration Cost?

Here is a cost overview for Chinese exporters across product categories:

Visit our pricing page for complete service details and volume pricing for companies with multiple facilities.

How Can Assurentry Help Chinese Exporters?

Assurentry provides comprehensive FDA compliance services designed for the unique challenges Chinese exporters face:

• FDA Facility Registration: Guided registration workflows for food, drug, device, and cosmetics facilities
• US Agent Services: Professional, always-available US Agent with prompt forwarding of FDA communications
• Import Alert Resolution: Expert guidance on corrective actions, documentation, and petitioning FDA for removal from import alerts
• Prior Notice Filing: Automated Prior Notice submissions for every food shipment
• Label Compliance Review: Expert review of your US-market labels to ensure FDA compliance before shipping
• Inspection Preparation: Guidance on preparing for FDA inspections of your Chinese facility, including cGMP readiness assessments
• Compliance Dashboard: Real-time visibility into registration status, import alerts, deadlines, and action items